| __timestamp | Regeneron Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2614539000 | 116287000 |
| Thursday, January 1, 2015 | 3711019000 | 136004000 |
| Friday, January 1, 2016 | 4560733000 | 203017000 |
| Sunday, January 1, 2017 | 5475166000 | 287023000 |
| Monday, January 1, 2018 | 6276700000 | 393541000 |
| Tuesday, January 1, 2019 | 7081200000 | 376095000 |
| Wednesday, January 1, 2020 | 7377200000 | 467938000 |
| Friday, January 1, 2021 | 13634200000 | 504714000 |
| Saturday, January 1, 2022 | 10612500000 | 580017000 |
| Sunday, January 1, 2023 | 11301400000 | 523742000 |
| Monday, January 1, 2024 | 12231500000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have showcased distinct trajectories in gross profit over the past decade. From 2014 to 2023, Regeneron has consistently outperformed, with a staggering 333% increase in gross profit, peaking at over $11 billion in 2023. This growth reflects Regeneron's strategic innovations and market expansions.
Conversely, Supernus Pharmaceuticals, while smaller in scale, has demonstrated a commendable 350% growth, reaching approximately $524 million in 2023. This growth underscores Supernus's niche focus and effective market penetration strategies.
The data highlights a broader trend in the pharmaceutical industry: the ability to leverage research and development into substantial financial gains. As we look to the future, these companies' trajectories offer insights into the evolving dynamics of pharmaceutical profitability.
Pfizer Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Bristol-Myers Squibb Company and Supernus Pharmaceuticals, Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Exelixis, Inc. or Supernus Pharmaceuticals, Inc.